[1]
|
Wen, X.T., Song, G., Hu, C.J., et al. (2020) Identification of Novel Serological Autoantibodies in Takayasu Arteritis Pa-tients Using HuProt Arrays. Molecular & Cellular Proteomics, 20, Article ID: 100036.
https://doi.org/10.1074/mcp.RA120.002119
|
[2]
|
Espinoza, J., Suzue, A. and Itaru, M. (2018) New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens, 7, Article No. 73. https://doi.org/10.3390/pathogens7030073
|
[3]
|
Villon, M.L.F.Z., de la Rocha, J.A.L. and Espinoza, L.R. (2020) Takayasu Arteritis: Recent Developments. Current Rheumatology Reports, 21, Article No. 45. https://doi.org/10.1007/s11926-019-0848-3
|
[4]
|
Kerr, G.S. (1994) Takayasu Arteritis. Annals of Internal Medicine, 120, 919-929.
https://doi.org/10.7326/0003-4819-120-11-199406010-00004
|
[5]
|
Bicakcigil, M., Aksu, K., Kamali, S., et al. (2009) Takayasu’s Arteritis in Turkey—Clinical and Angiographic Features of 248 Patients. Clinical & Experimental Rheumatology, 27, S59-S64.
|
[6]
|
Kaichiro, I. (1988) Diagnostic Approach and Proposed Criteria for the Clinical Diag-nosis of Takayasu’s Arteriopathy. Journal of the American College of Cardiology, 12, 964-972. https://doi.org/10.1016/0735-1097(88)90462-7
|
[7]
|
Bloch, D.A., Michel, B.A., Hunder, G.G., et al. (2010) The American College of Rheumatology 1990 Criteria for the Classification of Vasculitis: Patients and Methods. Arthritis & Rheumatism, 33, 1068-1073.
|
[8]
|
Grayson, P.C., Ponte, C., Suppiah, R., et al. (2022) 2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu Arteritis. Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research, 81, 1654-1660. https://doi.org/10.1136/ard-2022-223482
|
[9]
|
邹玉宝, 宋雷, 蒋雄京. 大动脉炎诊断标准研究进展[J]. 中国循环杂志, 2017, 32(1): 90-92.
https://doi.org/10.3969/j.issn.1000-3614.2017.01.021
|
[10]
|
吴思凡, 马莉莉, 陈慧勇, 等. 不同诊断/分类标准对大动脉炎诊断的价值研究[J]. 中华风湿病学杂志, 2021, 25(11): 727-732. https://doi.org/10.3760/cma.j.cn141217-20200426-00175
|
[11]
|
Keser, G., Direskeneli, H. and Aksu, K. (2014) Management of Takayasu Arteritis: A Systematic Review. Rheumatology, 53, 793-801. https://doi.org/10.1093/rheumatology/ket320
|
[12]
|
Sivakumar, M.R., Misra, R.N. and Bacon, P.A. (2005) OP14. The Indian Perspective of Takayasu Arteritis and Development of a Disease Extent Index (DEI.TAK) to Assess Takaya-su Arteritis. Rheumatology, 44, Iii6-Iii7.
https://doi.org/10.1093/rheumatology/keh739
|
[13]
|
Misra, R., Danda, D., Rajappa, S.M., et al. (2013) Development and Initial Validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology, 52, 1795-1801. https://doi.org/10.1093/rheumatology/ket128
|
[14]
|
Li, J., Wang, Y., Wang, Y., et al. (2020) Association between Acute Phase Reactants, Interleukin-6, Tumor Necrosis Factor-α, and Disease Activity in Takayasu’s Arteritis Patients. Arthritis Research & Therapy, 22, Article No. 285.
https://doi.org/10.1186/s13075-020-02365-y
|
[15]
|
Svensson, C., Eriksson, P. and Zachrisson, H. (2020) Vascular Ultrasound for Monitoring of Inflammatory Activity in Takayasu Arteritis. Clinical Physiology and Functional Imaging, 40, 37-45. https://doi.org/10.1111/cpf.12601
|
[16]
|
Mattay, R.R., Saucedo, J.F., Lehman, V.T., et al. (2021) Current Clinical Applications of Intracranial Vessel Wall MR Imaging. Seminars in Ultrasound CT and MRI, 42, 463-473. https://doi.org/10.1053/j.sult.2021.07.004
|
[17]
|
Song, J.W., Obusez, E.C., Raymond, S.B., et al. (2019) Vessel Wall MRI Added to MR Angiography in the Evaluation of Suspected Vasculopathies: Vessel Wall MRI with MRA. Journal of Neuroimaging, 29, 454-457.
https://doi.org/10.1111/jon.12607
|
[18]
|
Dejaco, C., Ramiro, S., Duftner, C., et al. (2018) EULAR Recommenda-tions for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice. Annals of the Rheumatic Diseases, 76, 24.
https://doi.org/10.1136/annrheumdis-2017-eular.7221
|
[19]
|
Kang, F., Han, Q., Zhou, X., et al. (2020) Performance of the PET Vascular Activity Score (PETVAS) for Qualitative and Quantitative Assessment of Inflammatory Activity in Takayasu’s Arteritis Patients. European Journal of Nuclear Medicine and Molecular Imaging, 47, 3107-3117. https://doi.org/10.1007/s00259-020-04871-2
|
[20]
|
Schfer, V.S., Jin, L. and Schmidt, W.A. (2020) Imaging for Di-agnosis, Monitoring, and Outcome Prediction of Large Vessel Vasculitides. Current Rheumatology Reports, 22, Article No. 76. https://doi.org/10.1007/s11926-020-00955-y
|
[21]
|
Hellmich, B., Gueda, A.F., Monti, S., et al. (2020) Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future. Current Rheumatology Reports, 22, Arti-cle No. 84. https://doi.org/10.1007/s11926-020-00964-x
|
[22]
|
Seyahi, E., Ugurlu, S., Cumali, R., et al. (2006) Ath-erosclerosis in Takayasu Arteritis. Annals of the Rheumatic Diseases, 65, 1202-1207. https://doi.org/10.1136/ard.2005.047498
|
[23]
|
Numano, F., Shimokado, K., Kishi, Y., et al. (1982) Changes in the Plasma Levels of Thromboxane B2 and Cyclic Nucleotides in Patients with Takayasu Disease. Japanese Circulation Journal, 46, 16-20.
https://doi.org/10.1253/jcj.46.16
|
[24]
|
Akazawa, H., Ikeda, U., Yamamoto, K., et al. (1996) Hypercoagulable State in Patients with Takayasu’s Arteritis. Thrombosis and Haemostasis, 75, 712-716. https://doi.org/10.1055/s-0038-1650353
|
[25]
|
Wu, S., Kong, X., Cui, X., et al. (2023) Effectiveness and Safety of Tocilizumab in Patients with Refractory or Severe Takayasu’s Arteritis: A Prospective Cohort Study in a Chinese Popu-lation. Joint Bone Spine, 88, Article ID: 105186.
https://doi.org/10.1016/j.jbspin.2021.105186
|
[26]
|
Cui, X., Kong, X., Chen, R., Ma, L. and Jiang, L. (2020) The Potential Role of Leflunomide in Inhibiting Vascular Fibrosis by Down-Regulating Type-II Macrophages in Takayasu’s Arteritis. Clinical and Experimental Rheumatology, 38, S69-S78.
|
[27]
|
Schmidt, J., Kermani, T.A., Bacani, A.K., et al. (2012) Tumor Necrosis Factor Inhibitors in Patients with Takayasu Arteritis: Experience from a Referral Center with Long-Term Follow-Up. Arthritis Care & Research, 64, 1079-1083.
https://doi.org/10.1002/acr.21636
|
[28]
|
Hoffman, G.S., Merkel, P.A., Brasington, R.D., et al. (2004) Anti-Tumor Necrosis Factor Therapy in Patients with Difficult to Treat Takayasu Arteritis. Arthritis & Rheumatism, 50, 2296-2304. https://doi.org/10.1002/art.20300
|
[29]
|
Molloy, E.S., Langford, C.A., Clark, T.M., et al. (2008) Anti-Tumour Ne-crosis Factor Therapy in Patients with Refractory Takayasu Arteritis: Long-Term Follow-Up. Annals of the Rheumatic Diseases, 67, 1567-1569.
https://doi.org/10.1136/ard.2008.093260
|
[30]
|
Arita, Y., Nakaoka, Y., Eda, Y., et al. (2020) Perioperative Man-agement of Takayasu Arteritis for Cardiac Surgery in a Patient Treated with Tocilizumab. JACC Case Reports, 2, 2363-2367. https://doi.org/10.1016/j.jaccas.2020.07.039
|
[31]
|
邢月浩, 郭建明, 谷涌泉. 多发性大动脉炎血管内介入治疗和开放手术现状[J]. 介入放射学杂志, 2019, 28(6): 599-602.
|